COVID-19 trials registries data warehouse

https://www.thaiclinicaltrials.org/show/TCTR20220302001

Chaicharn Pothirat

chaicharn.p@cmu.ac.th

2022-03-02

Recruiting

RCT

Randomized

Parallel

Open label

single-center

Treatment

1. Inpatients diagnosed with mild to moderated COVID-19 pneumonia (Infiltration in CXR and oxygen saturation (SpO2) equal or greater than 94% on room air. The CXR will be written by pulmonologists and/or radiologists at the first day of admission or the first day of perform CXR. 2. aged equal or greater than 18 years old

1. COPD and asthma treated with ICS in the past 4 week 2. had recent use (within 7 days) of inhaled or systemic glucocorticoids 3. had a known allergy or contraindication to inhaled budesonide 4. subjects who have participated in the other clinical trial

2

Faculty of Medicine; Chiang Mai University

18

100

Thailand

Mild/moderate disease at enrollment

2: Mild/moderate disease at enrollment

76

Severe pneumonia event 1 time measured at the day of discharge or patient turn to severe pneumonia Number of case with severe pneumonia

Phase 3

[{"arm_notes": "", "treatment_id": 242, "treatment_name": "Budesonide", "treatment_type": "Corticosteroids", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]